His primary areas of study are Internal medicine, Cardiology, Anesthesia, Myocardial infarction and Heart disease. His research related to Heart failure, Pravastatin, Coronary artery disease, Digoxin and Verapamil might be considered part of Internal medicine. The Pravastatin study combines topics in areas such as Statin, Vascular disease and Coronary atherosclerosis.
He regularly ties together related areas like Heart rate in his Cardiology studies. His biological study spans a wide range of topics, including Ischemia, Randomized controlled trial, Angina and Clinical trial. His Myocardial infarction research integrates issues from Thrombosis, Surgery and Left bundle branch block.
Kong I. Lie focuses on Internal medicine, Cardiology, Anesthesia, Myocardial infarction and Heart failure. Heart disease, Coronary artery disease, Heart rate, Hemodynamics and Tachycardia are the subjects of his Internal medicine studies. His work on Ejection fraction, Atrial fibrillation, Angina and Electrocardiography is typically connected to In patient as part of general Cardiology study, connecting several disciplines of science.
His Anesthesia research includes elements of Bisoprolol, Diltiazem and Flecainide. As part of the same scientific family, Kong I. Lie usually focuses on Myocardial infarction, concentrating on Surgery and intersecting with Angioplasty. His Heart failure research is multidisciplinary, relying on both Endocrinology, Angiotensin-converting enzyme and Captopril.
Kong I. Lie mainly investigates Internal medicine, Cardiology, Heart failure, Myocardial infarction and Coronary artery disease. His research in Internal medicine intersects with topics in Endocrinology and Surgery. His study looks at the relationship between Cardiology and fields such as Anesthesia, as well as how they intersect with chemical problems.
His research in Heart failure tackles topics such as Heart rate variability which are related to areas like Autonomic nervous system and Electrocardiography. His research integrates issues of Odds ratio, Ventricular fibrillation, Dilated cardiomyopathy and Chest pain in his study of Myocardial infarction. The various areas that Kong I. Lie examines in his Coronary artery disease study include Statin, Nuclear medicine, Radiology, Perfusion and Asymptomatic.
His primary scientific interests are in Internal medicine, Cardiology, Heart disease, Heart failure and Surgery. His research on Internal medicine frequently connects to adjacent areas such as Endocrinology. His Cardiology research is multidisciplinary, incorporating perspectives in Anesthesia and Risk factor.
He has included themes like Anticoagulant and Antithrombotic in his Anesthesia study. His work in Heart failure covers topics such as Atrial natriuretic peptide which are related to areas like Aldosterone, Chronic atrial fibrillation, Pathophysiology and P wave. His work investigates the relationship between Surgery and topics such as Myocardial infarction that intersect with problems in Cardiopulmonary bypass, Aprotinin, Blood transfusion and Perioperative.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Effects of Lipid Lowering by Pravastatin on Progression and Regression of Coronary Artery Disease in Symptomatic Men With Normal to Moderately Elevated Serum Cholesterol Levels The Regression Growth Evaluation Statin Study (REGRESS)
J. Wouter Jukema;Albert V.G. Bruschke;Ad J. van Boven;Johan H.C. Reiber.
The role of a common variant of the cholesteryl ester transfer protein gene in the progression of coronary atherosclerosis. The Regression Growth Evaluation Statin Study Group
J. A. Kuivenhoven;J. W. Jukema;A. H. Zwinderman;P. De Knijff.
The New England Journal of Medicine (1998)
Lidocaine in the prevention of primary ventricular fibrillation. A double-blind, randomized study of 212 consecutive patients.
K I Lie;H J Wellens;F J van Capelle;D Durrer.
The New England Journal of Medicine (1974)
Observations on mechanisms of ventricular tachycardia in man.
Hein J. J. Wellens;Donald R. Düren;K. I. Lie.
To operate or not on elderly patients with aortic stenosis: the decision and its consequences
B J Bouma;R B A van den Brink;J H P van der Meulen;H A Verheul.
Early treatment of unstable angina in the coronary care unit: a randomised, double blind, placebo controlled comparison of recurrent ischaemia in patients treated with nifedipine or metoprolol or both
F. L. Meijler;A. C. Arntzenuis;A. J. Dunning;P. G. Hugenholtz.
THE VALUE OF CLASS-IC ANTIARRHYTHMIC DRUGS FOR ACUTE CONVERSION OF PAROXYSMAL ATRIAL-FIBRILLATION OR FLUTTER TO SINUS RHYTHM
Maarten J. Suttorp;J.Herre Kingma;Emile R. Jessurun;Loraine Lie-A-Huen.
Journal of the American College of Cardiology (1990)
Randomised study of effect of ibopamine on survival in patients with advanced severe heart failure
J R Hampton;D J van Veldhuisen;F X Kleber;A J Cowley.
The Lancet (1997)
B-Mode Ultrasound Assessment of Pravastatin Treatment Effect on Carotid and Femoral Artery Walls and Its Correlations With Coronary Arteriographic Findings: A Report of the Regression Growth Evaluation Statin Study (REGRESS)
Eric de Groot;J.Wouter Jukema;Alexander D. Montauban van Swijndregt;Aeilko H. Zwinderman.
Journal of the American College of Cardiology (1998)
Chronic atrial fibrillation - Success of serial cardioversion therapy and safety of oral anticoagulation
I.C. van Gelder;H.J.G.M. Crijns;R.G. Tieleman;J. Brugemann.
JAMA Internal Medicine (1996)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: